Oncotarget

Vol 11, No 14

April 7, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 14 of Oncotarget features Figure 5, "Effect of 15-day incubation of BI 1002494 on T-47D breast cancer cells cultivated in alginate capsules in a bioreactor," by Lamb, et al.

Table of Contents

Research Papers

Novel plant microRNAs from broccoletti sprouts do not show cross-kingdom regulation of pancreatic cancer

Novel plant microRNAs from broccoletti sprouts do not show cross-kingdom regulation of pancreatic cancer

https://doi.org/10.18632/oncotarget.27527

Xi Xiao, Carsten Sticht, Libo Yin, Li Liu, Svetlana Karakhanova, Yefeng Yin, Christina Georgikou, Jury Gladkich, Wolfgang Gross, Norbert Gretz,  and Ingrid Herr
1203-1217
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy

A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy

https://doi.org/10.18632/oncotarget.27529

Nagi B. Kumar, Julio Pow-Sang, Philippe Spiess, Shohreh Dickinson,  and Michael J. Schell
1218-1234
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies

A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies

https://doi.org/10.18632/oncotarget.27530

Matthew H. Taylor, Ajjai S. Alva, Timothy Larson, Sebastian Szpakowski, Das Purkaystha, Alpesh Amin, Linda Karpiak,  and Sarina A. Piha-Paul
1235-1243
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Does breast carcinoma belong to the Lynch syndrome tumor spectrum? – Somatic mutational profiles vs. ovarian and colorectal carcinomas

Does breast carcinoma belong to the Lynch syndrome tumor spectrum? – Somatic mutational profiles vs. ovarian and colorectal carcinomas

https://doi.org/10.18632/oncotarget.27538

Noora K. Porkka, Alisa Olkinuora, Teijo Kuopio, Maarit Ahtiainen, Samuli Eldfors, Henrikki Almusa, Jukka-Pekka Mecklin,  and Päivi Peltomäki
1244-1256
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells

Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells

https://doi.org/10.18632/oncotarget.27545

David J. Lamb, Aleksander Rust, Albin Rudisch, Tobias Glüxam, Nathalie Harrer, Herwig Machat, Ingrid Christ, Florian Colbatzky, Andreas Wernitznig, Annika Osswald,  and Wolfgang Sommergruber
1257-1272
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

First-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynamics in prostate cancer patients

First-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynamics in prostate cancer patients

https://doi.org/10.18632/oncotarget.27549

Natalia V. Eremina, Vasily I. Kazey, Sergey V. Mishugin, Roman V. Leonenkov, Dmitry Y. Pushkar, Vadim L. Mett,  and Andrei V. Gudkov
1273-1288
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Corrections

Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models

Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models

https://doi.org/10.18632/oncotarget.27407

Sunkyu Kim, Ralph Tiedt, Alice Loo, Thomas Horn, Scott Delach, Steven Kovats, Kristy Haas, Barbara Schacher Engstler, Alexander Cao, Maria Pinzon-Ortiz, Iain Mulford, Michael G. Acker, Rajiv Chopra, Christopher Brain, Emmanuelle di Tomaso, William R. Sellers,  and Giordano Caponigro
1289-1289
Correction  |  PDF  |  How to cite

Correction: Exclusive destruction of mitotic spindles in human cancer cells

Correction: Exclusive destruction of mitotic spindles in human cancer cells

https://doi.org/10.18632/oncotarget.27499

Leonid Visochek, Asher Castiel, Leonid Mittelman, Michael Elkin, Dikla Atias, Talia Golan, Shai Izraeli, Tamar Peretz,  and Malka Cohen-Armon
1290-1291
Correction  |  PDF  |  How to cite


Copyright © 2020 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC